AL
LOW icon

Aspiriant LLC’s Lowe's Companies LOW Stock Holding History

Aspiriant LLC’s Portfolio LOW Stock Details LOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.61M Sell
6,823
-438
-6% -$114K 0.05% 126
2025
Q4 		$1.75M Buy
7,261
+227
+3% +$54.5K 0.05% 122
2025
Q3 		$1.77M Buy
7,034
+421
+6% +$103K 0.05% 108
2025
Q2 		$1.47M Sell
6,613
-13
-0.2% -$2.9K 0.05% 121
2025
Q1 		$1.55M Buy
6,626
+47
+0.7% +$11.6K 0.05% 109
2024
Q4 		$1.62M Sell
6,579
-68
-1% -$18.2K 0.06% 106
2024
Q3 		$1.8M Buy
6,647
+73
+1% +$17.7K 0.07% 99
2024
Q2 		$1.45M Sell
6,574
-1,062
-14% -$242K 0.06% 105
2024
Q1 		$1.95M Buy
7,636
+132
+2% +$30.3K 0.08% 96
2023
Q4 		$1.67M Sell
7,504
-276
-4% -$55.9K 0.08% 104
2023
Q3 		$1.62M Sell
7,780
-568
-7% -$128K 0.08% 100
2023
Q2 		$1.88M Buy
8,348
+1,497
+22% +$311K 0.1% 94
2023
Q1 		$1.37M Buy
6,851
+28
+0.4% +$5.69K 0.07% 107
2022
Q4 		$1.36M Buy
6,823
+420
+7% +$83.9K 0.07% 105
2022
Q3 		$1.2M Buy
6,403
+127
+2% +$24.7K 0.06% 106
2022
Q2 		$1.1M Sell
6,276
-148
-2% -$28.5K 0.05% 114
2022
Q1 		$1.3M Buy
6,424
+339
+6% +$78K 0.07% 116
2021
Q4 		$1.57M Buy
6,085
+16
+0.3% +$3.8K 0.08% 104
2021
Q3 		$1.23M Buy
6,069
+2
+0% +$399 0.07% 105
2021
Q2 		$1.18M Sell
6,067
-170
-3% -$33.3K 0.07% 105
2021
Q1 		$1.19M Sell
6,237
-24
-0.4% -$4.12K 0.08% 91
2020
Q4 		$1.01M Sell
6,261
-3,981
-39% -$647K 0.07% 100
2020
Q3 		$1.7M Buy
10,242
+3,739
+57% +$576K 0.13% 74
2020
Q2 		$879K Buy
6,503
+24
+0.4% +$2.74K 0.08% 91
2020
Q1 		$558K Sell
6,479
-1,731
-21% -$189K 0.06% 118
2019
Q4 		$985K Sell
8,210
-290
-3% -$33.2K 0.09% 97
2019
Q3 		$936K Buy
8,500
+4,760
+127% +$502K 0.08% 111
2019
Q2 		$376K Hold
3,740
– – 0.03% 167
2019
Q1 		$411K Sell
3,740
-375
-9% -$37.4K 0.03% 156
2018
Q4 		$380K Buy
4,115
+469
+13% +$45.2K 0.03% 164
2018
Q3 		$418K Buy
3,646
+79
+2% +$8.23K 0.04% 166
2018
Q2 		$341K Buy
+3,567
New +$323K 0.03% 194

Other funds holding LOW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aspiriant LLC's LOW Position: Q1 2026 in Review

Aspiriant LLC reduced its Lowe's Companies (LOW) stake by 6% in Q1 2026, selling an estimated $114K and leaving 6,823 shares worth $1.61M. The position accounts for 0.05% of the portfolio, ranked #126.

Aspiriant LLC first reported a position in LOW in Q2 2018 and has held it in 32 quarters since. The position peaked at $1.95M in Q1 2024. 2,681 funds tracked by Wall St. Rank hold LOW as of Q1 2026.

  • Aspiriant LLC held 6,823 shares of Lowe's Companies worth $1.61M as of Q1 2026.
  • Aspiriant LLC sold 438 Lowe's Companies shares in Q1 2026, an estimated $114K.
  • Lowe's Companies made up 0.05% of Aspiriant LLC's portfolio in Q1 2026, its #126 holding.
  • Aspiriant LLC first reported a position in Lowe's Companies in Q2 2018 and has held it in 32 quarters since.
  • Aspiriant LLC's Lowe's Companies position peaked at $1.95M in Q1 2024.
  • 2,681 funds tracked by Wall St. Rank held Lowe's Companies as of Q1 2026.

Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.